Karyopharm Therapeutics is under fresh scrutiny as analysts reaffirm a $28 price target while keeping the central fair value estimate steady at $15.33. That target is being framed largely around ...

A tiny house with the features of a container home, Erica offers residential features and customizable interiors, which make ...